Literature DB >> 24752055

Tumor regression grading in rectal cancer: is it time to move forward?

Vincenzo Valentini1, Bruce D Minsky2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24752055     DOI： 10.1200/JCO.2014.55.4766

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Yulia Lakhman; Romain Sudre; Richard K G Do; Frederic Bibeau; David Azria; Eric Assenat; Nicolas Molinari; Marie-Ange Pierredon; Philippe Rouanet; Boris Guiu
Journal:  Radiology       Date:  2016-02-26       Impact factor: 11.105

2.  MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.

Authors:  T Seierstad; K H Hole; K K Grøholt; S Dueland; A H Ree; K Flatmark; K R Redalen
Journal:  Br J Radiol       Date:  2015-04-22       Impact factor: 3.039

3.  Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy.

Authors:  Filippo Landi; Eloy Espín; Victor Rodrigues; Francesc Vallribera; Aleix Martinez; Cecile Charpy; Francesco Brunetti; Daniel Azoulay; Nicola de'Angelis
Journal:  Int J Colorectal Dis       Date:  2016-10-19       Impact factor: 2.571

4.  YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.

Authors:  Rebecca Senetta; Eleonora Duregon; Cristina Sonetto; Rossella Spadi; Massimiliano Mistrangelo; Patrizia Racca; Luigi Chiusa; Fernando H Munoz; Umberto Ricardi; Alberto Arezzo; Adele Cassenti; Isabella Castellano; Mauro Papotti; Mario Morino; Mauro Risio; Paola Cassoni
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

5.  Short-term Outcomes of an Extralevator Abdominoperineal Resection in the Prone Position Compared With a Conventional Abdominoperineal Resection for Advanced Low Rectal Cancer: The Early Experience at a Single Institution.

Authors:  Seungwan Park; Hyuk Hur; Byung Soh Min; Nam Kyu Kim
Journal:  Ann Coloproctol       Date:  2016-02-29

6.  A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy.

Authors:  Ping-Bao Zhang; Zi-Li Huang; Jia-Bei Li; Xiu-Yan Huang
Journal:  Cancer Manag Res       Date:  2019-12-27       Impact factor: 3.989

7.  A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.

Authors:  Nick J Battersby; Mit Dattani; Sheela Rao; David Cunningham; Diana Tait; Richard Adams; Brendan J Moran; Shelize Khakoo; Paris Tekkis; Shahnawaz Rasheed; Alex Mirnezami; Philip Quirke; Nicholas P West; Iris Nagtegaal; Irene Chong; Anguraj Sadanandam; Nicola Valeri; Karen Thomas; Michelle Frost; Gina Brown
Journal:  Trials       Date:  2017-08-29       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.